P1237: PRELIMINARY RESULTS OF A PHASE Ⅱ STUDY OF ZANUBRUTINIB COMBINED WITH IMMUNOCHEMOTHERAPY IN PATIENTS WITH CD79A/CD79B-MUTANT DIFFUSE LARGE B-CELL LYMPHOMA

Detalles Bibliográficos
Autores principales: Yan, Z., Yao, S., Wang, H., Chu, J., Zhao, S., Ma, J., Wei, B., Zheng, J., Lin, Q., Xu, Z., yao, Z., liu, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430540/
http://dx.doi.org/10.1097/01.HS9.0000847812.32219.ad

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430540/
http://dx.doi.org/10.1097/01.HS9.0000847812.32219.ad

Ejemplares similares